What makes an early-stage company stand out to investors, and what can stop a promising startup from being investment-ready? Cara Schoettes of Sims Venture Capital and Isaiah Reeves of Solas BioVentures share investors’ perspectives on what matters when evaluating early-stage companies. This session explores the key factors investors consider, common gaps and red flags they encounter, and how founders can better position their companies for investment. Viewers will learn practical insights they can use to assess their own readiness and strengthen their approach to future investor conversations.
